Enzymotec (ENZY) in Focus: Stock Surges 10.3% – Tale of the Tape

Zacks

Enzymotec Ltd. (ENZY) was a big mover last session, as the company saw its shares rise over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 25.2 % since Feb 11, 2015.

The company has seen 2 negative revisions in the past 30 days, while its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher can last.

Enzymotec currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.

A better-ranked biotechnology stock is Phibro Animal Health Corporation (PAHC), sporting a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply